These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21030358)

  • 41. [An open study on the efficacy and tolerability of quetiapine treatment of patients with schizophrenia].
    Beszłej JA; Grzesiak M
    Psychiatr Pol; 2005; 39(2):293-307. PubMed ID: 15881624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quetiapine-associated dysphagia.
    Kohen I; Lester P
    World J Biol Psychiatry; 2009; 10(4 Pt 2):623-5. PubMed ID: 18615368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quetiapine-induced dystonia and agitation in Parkinson's disease with dementia: a case report.
    Leey J; Setters B; Murphy P; Antimisiaris D; Miles T
    J Am Geriatr Soc; 2009 May; 57(5):918-9. PubMed ID: 19470011
    [No Abstract]   [Full Text] [Related]  

  • 44. Acute pancreatitis associated with quetiapine use in schizophrenia.
    Chang TG; Chiu NY; Hsu WY
    J Clin Psychopharmacol; 2014 Jun; 34(3):382-3. PubMed ID: 24699039
    [No Abstract]   [Full Text] [Related]  

  • 45. Switching to quetiapine in patients with acute mania who were intolerant to risperidone.
    Pae CU; Lee KU; Kim JJ; Lee CU; Bahk WM; Lee SJ; Lee C; Paik IH
    Hum Psychopharmacol; 2004 Jan; 19(1):47-51. PubMed ID: 14716712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Early phase II study of quetiapine fumarate on schizophrenia].
    Murasaki M; Yamauchi T; Yagi G; Nakajima T; Nakane Y; Kudo Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Apr; 19(2):53-66. PubMed ID: 10464776
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quetiapine in the treatment of sleep disturbances associated with addictive conditions: a retrospective study.
    Terán A; Majadas S; Galan J
    Subst Use Misuse; 2008 Dec; 43(14):2169-71. PubMed ID: 19085442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Quetiapine in the treatment of the Gilles de la Tourette syndrome. A case study].
    Neves Ramos D; van West D; van Strien AP
    Tijdschr Psychiatr; 2007; 49(4):263-7. PubMed ID: 17436213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term adjunctive quetiapine may reduce substance use--a preliminary retrospective study.
    Sattar SP; Schultz SK; Arndt S; Soundy T; Petty F
    S D Med; 2007 Nov; 60(11):437, 439-41, 443 passim. PubMed ID: 18196687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intranasal quetiapine abuse.
    Pierre JM; Shnayder I; Wirshing DA; Wirshing WC
    Am J Psychiatry; 2004 Sep; 161(9):1718. PubMed ID: 15337673
    [No Abstract]   [Full Text] [Related]  

  • 51. Safety and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: pooled data from randomised, double-blind, placebo-controlled studies.
    Meulien D; Huizar K; Brecher M
    Hum Psychopharmacol; 2010 Mar; 25(2):103-15. PubMed ID: 20196185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quetiapine: novel uses in the treatment of depressive and anxiety disorders.
    Ravindran AV; Al-Subaie A; Abraham G
    Expert Opin Investig Drugs; 2010 Oct; 19(10):1187-204. PubMed ID: 20795889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The uses and outcomes of quetiapine in depressive and bipolar mood disorders in clinical practice.
    Shajahan P; Taylor M
    J Psychopharmacol; 2010 Apr; 24(4):565-72. PubMed ID: 19164493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic insomnia secondary to chronic pain responding to quetiapine.
    Fernando A; Chew G
    Australas Psychiatry; 2005 Mar; 13(1):86. PubMed ID: 15777423
    [No Abstract]   [Full Text] [Related]  

  • 55. Enhanced bleeding risk in an elderly dementia patient treated with warfarin and quetiapine.
    Chen TY; Lin CE; Chen LF; Tzeng NS
    J Neuropsychiatry Clin Neurosci; 2013; 25(4):E25. PubMed ID: 24247877
    [No Abstract]   [Full Text] [Related]  

  • 56. The effect of quetiapine in psychotic Parkinsonian patients with and without dementia. An open-labeled study utilizing a structured interview.
    Prohorov T; Klein C; Miniovitz A; Dobronevsky E; Rabey JM
    J Neurol; 2006 Feb; 253(2):171-5. PubMed ID: 16096815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stimulant treatment of frontotemporal dementia in 8 patients.
    Huey ED; Garcia C; Wassermann EM; Tierney MC; Grafman J
    J Clin Psychiatry; 2008 Dec; 69(12):1981-2. PubMed ID: 19203481
    [No Abstract]   [Full Text] [Related]  

  • 58. Comment on: low-dose quetiapine-induced severe rhabdomyolysis.
    Ceri M; Unverdi S; Altay M; Duranay M
    Ren Fail; 2011; 33(4):463-4. PubMed ID: 21529278
    [No Abstract]   [Full Text] [Related]  

  • 59. Off-label Use of Quetiapine in Medical Inpatients and Postdischarge.
    Lee TC; Desforges P; Murray J; Saleh RR; McDonald EG
    JAMA Intern Med; 2016 Sep; 176(9):1390-1. PubMed ID: 27400391
    [No Abstract]   [Full Text] [Related]  

  • 60. Quetiapine for treatment-resistant delirium.
    Al-Samarrai S; Dunn J; Newmark T; Gupta S
    Psychosomatics; 2003; 44(4):350-1. PubMed ID: 12832605
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.